Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.08

-2.9%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (1222)	6/23/2000 2:32:00 PM
From: Mike McFarland	Read Replies (3) of 52153

What pharma-bio pair is next? Strange that pharma has the money to spend now, when biotech was being starved out a year ago. I should think we will see more deals like this--in just a few years MLNM seems to have created a real powerhouse and there seem to be plenty of second and third tier biotechs that are rather cheap, and could have so much more potential in the right hands--or if managements watch mlnm and somehow become inspired. When this amateur biotech enthusiast looks over the field, I see these mutt mlnm's, or poor man mlnm's, I've bought more Axys down here at $5. But when I see deals like this go off in the better first tier names, I really grit my teeth. I want to say to Axys managment--are you going to piss this moment away? I have that thought will a lot of my third tier biotechs, and while I cannot complain, having caught the biotech wave--I'd go back in time and trade them all for MLNM a year ago if I could. Maybe I still will, on dips of course.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next